Identifying the Mechanisms of Liver Cancer Cell Drug Resistance
CSEF · 2018 Biochemistry/ Molecular Biology
Overview
Objectives/Goals This project was designed to understand potential mechanisms of drug resistance in human liver cancer cell lines. Methods/Materials The liver cancer drug, Tetrandrine (TET), was used to screen the most drug-resistant and drug-sensitive liver cancer cell line. Both cell lines were treated with 6 micro-molars TET and underwent bulk RNA sequencing. The drug-resistant cell line was treated with 20 micro-molars TET and underwent single-cell RNA sequencing. Sequencing data analysis was conducted on my laptop on Linux server and RStudio. Results Data analysis from the bulk and single-cell RNA sequencing revealed the top up-regulated genes and pathways the cell lines had after drug treatment. The unfolded protein response (UPR) was up-regulated in both the drug resistant and drug-sensitive cell line from both the bulk and single-cell RNA results. Additionally, from the bulk-RNA sequencing, it was found that IRE1 signaling was up-regulated only in the drug-resistant cell line while PERK signaling was up-regulated only in the drug-sensitive cell line. Conclusions/Discussion These results reveal that selective UPR activation is linked to drug resistance in liver cancer cells. UPR leads to the activation of the PERK and IRE1 signaling pathways. As previous literature has concluded that IRE1 signaling leads to cell proliferation while PERK signaling leads to cell death, I concluded that these two antagonistic pathways are possible mechanisms of drug resistance and drug sensitivity, respectively. As liver cancer has a very heterogeneous and poorly understood genetic landscape, the identification of UPR and its downstream signaling pathways (IRE1 and PERK) will shed light into the mechanisms of liver cancer cell drug resistance and help develop effective approaches to sensitize liver cancer to drug treatment.
Summary statement
Using RNA sequencing technologies, I found that the up-regulation of IRE1 signaling in the unfolded protein response is a possible mechanism of liver cancer cell drug resistance.
Help received
I designed and performed the experiment, and I analyzed the results. My mentors, Dr. Xiwei Wu and Dr. Juan Du, taught me the procedures of culturing and treating cells, and using computer software to analyze RNA sequencing data.
Competition history
- CSEF 2018
Resources
Related projects
ISEF · 2020
Examining Mechanisms of Resistance in Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells
CSEF · 2019
Epigenetic Therapy for Liver Cancer: The Effect of 5-Azacytidine on the Expression of Tumor Suppressor Genes
ISEF · 2023
Identification and Analysis of Metabolic Inhibitors in Ctnnb1-Driven Hepatocellular Carcinoma (HCC)
CSEF · 2008
The Effects of a Fatty Acid Synthase Inhibitor on Multi-drug Resistant Ovarian Cancer Cells
CSEF · 2002
The Effect of Directing Ribozymes to Attack Proliferating Cell Nuclear Antigens and Inhibit the Growth of Cancer Cells
CSEF · 2026
Defining the Commitment Point to Drug Resistance in Melanoma Through Single-Cell Transcriptomics and Epigenetics
CSEF · 2009
Mechanisms of Survival Against a Fatty Acid Synthase Inhibitor in Multidrug Resistant Ovarian Cancer
ISEF · 2023
Targeting Drug Resistant Cancer Cells by Plant Based Bio-Active Compounds
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects